Ibrutinib 140mg Tablet – Imported

Product Overview

Ibrutinib 140mg Tablet is a targeted prescription medicine containing ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor. It works by blocking specific signalling pathways that help certain abnormal B cells survive and multiply.

Ibrutinib is prescribed by specialists for selected blood cancers and related conditions, including chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), and Waldenström’s macroglobulinaemia, depending on the patient’s diagnosis and applicable treatment guidelines.

This imported product listing specifies Lucius Pharmaceuticals as the manufacturer and a pack size of 120 tablets. Ibrutinib is a specialist medicine that requires a valid prescription, careful monitoring, and guidance from a qualified healthcare professional.

Key Product Information

• Product Name: Ibrutinib 140mg Tablet
• Generic Name: Ibrutinib
• Strength: 140mg
• Dosage Form: Tablet, as specified in the listing
• Manufacturer: Lucius Pharmaceuticals
• Pack Size: 120 Tablets
• Product Type: Imported Medicine
• Drug Class: Bruton’s Tyrosine Kinase (BTK) Inhibitor
• Therapeutic Category: Targeted Anticancer Medicine
• Primary Use: Treatment of certain blood cancers and related conditions

Verify the formulation, manufacturer, and pack contents against the original packaging before publishing or purchasing this product.

Uses of Ibrutinib 140mg Tablet

Ibrutinib may be prescribed for certain conditions involving abnormal B lymphocytes.

1. Chronic Lymphocytic Leukaemia (CLL)

CLL is a blood cancer characterised by the accumulation of abnormal lymphocytes. Ibrutinib can help control disease activity in eligible patients.

2. Small Lymphocytic Lymphoma (SLL)

SLL is a type of non-Hodgkin lymphoma closely related to CLL. Ibrutinib may be used when indicated by a specialist.

3. Waldenström’s Macroglobulinaemia

This rare blood cancer affects lymphoplasmacytic cells. Ibrutinib may be prescribed to appropriate patients according to their clinical circumstances.

4. Other Approved Conditions

Depending on the jurisdiction and prescribing guidelines, ibrutinib may also be used for selected cases of mantle cell lymphoma, marginal zone lymphoma, and chronic graft-versus-host disease.

The appropriate indication depends on the patient’s diagnosis, treatment history, and current prescribing guidance.

How Does Ibrutinib Work?

Ibrutinib blocks Bruton’s tyrosine kinase, a protein involved in B-cell receptor signalling. This pathway plays a role in the growth, survival, and movement of certain B cells.

By inhibiting BTK, ibrutinib interferes with signals that help abnormal cells survive and interact with their surrounding environment. This can help control disease activity in patients whose conditions respond to this treatment.

Ibrutinib is a targeted therapy and should only be used for an appropriate, medically confirmed indication.

Dosage and How to Take Ibrutinib 140mg

Ibrutinib should be taken exactly as prescribed by an oncology or haematology specialist.

• Follow the dose and schedule provided by your prescribing healthcare professional.
• Confirm the formulation and follow the instructions supplied with the actual product.
• Do not change your dose or interrupt treatment without medical advice.
• If you miss a dose, follow the product-specific instructions or contact your pharmacist.
• Do not take an extra dose to compensate for a missed dose.
• Inform your doctor about all prescription medicines, non-prescription products, and supplements you use.
• Attend all recommended follow-up appointments and laboratory tests.

Important: The 140mg strength does not necessarily represent the complete daily dose. The prescribed regimen depends on the condition being treated, other medicines, tolerability, and individual clinical factors.

Possible Side Effects

Ibrutinib can cause side effects, and some may require prompt medical attention.

Possible side effects include:

• Diarrhoea
• Fatigue or weakness
• Nausea
• Muscle or joint pain
• Bruising
• Skin rash
• Reduced blood cell counts
• Increased susceptibility to infections
• High blood pressure
• Abnormal heart rhythms

Serious Side Effects

Bleeding: Ibrutinib can increase bleeding risk. Seek urgent medical attention for severe bleeding, black stools, or blood in the urine.

Infections: Fever, chills, or other signs of infection should be reported promptly.

Heart problems: A fast or irregular heartbeat, chest pain, fainting, or shortness of breath requires urgent assessment.

Low blood counts: Regular blood tests may be needed to monitor anaemia, low platelets, and reduced white blood cells.

Liver problems: Yellowing of the skin or eyes, dark urine, or unusual abdominal discomfort should be assessed promptly.

Side effects vary between patients. Contact your healthcare professional if you develop new, persistent, or worsening symptoms.

Precautions and Warnings

Before starting treatment, tell your doctor about your medical history and current medicines.

Bleeding Risk

Inform your healthcare professional if you take anticoagulants, antiplatelet medicines, or other products that affect blood clotting. Discuss planned surgery or dental procedures before treatment.

Infection Risk

Ibrutinib may affect immune function. Report fever or suspected infection promptly and attend scheduled blood tests.

Heart and Blood Pressure

Tell your doctor about a history of heart disease, irregular heartbeat, or hypertension. Your blood pressure and heart rhythm may require monitoring.

Pregnancy and Breastfeeding

Ibrutinib may cause harm during pregnancy. Discuss contraception and pregnancy planning with your specialist. Ask your healthcare professional before breastfeeding during treatment.

Liver Conditions

Inform your doctor if you have liver disease, as this may affect treatment suitability or dosing.

Regular Monitoring

Your specialist may recommend blood counts, blood pressure measurements, liver tests, and other assessments throughout treatment.

Drug Interactions

Some medicines can change ibrutinib levels in the body or increase the risk of adverse effects.

Potential interactions include:

• Certain antifungal medicines
• Some antibiotics and antiviral medicines
• Anticoagulants and antiplatelet medicines
• Medicines that affect CYP3A enzymes
• Certain herbal supplements, including St John’s wort

Always provide your doctor or pharmacist with a complete list of medicines and supplements. Do not start, stop, or change any treatment without professional advice.

Who Should Use Ibrutinib 140mg?

Ibrutinib may be appropriate for patients with a specific blood cancer or related condition for which the medicine is indicated. A qualified specialist must assess whether its expected benefits outweigh its risks.

It is not suitable for self-medication or for treating an undiagnosed condition. Treatment decisions depend on the diagnosis, previous therapies, other medical conditions, blood test results, and possible drug interactions.

Storage Instructions

• Follow the storage instructions on the original packaging.
• Keep the medicine in its original packaging when appropriate.
• Protect it from excessive heat and moisture.
• Keep it out of the reach of children and pets.
• Do not use it after the expiry date.
• Do not use the product if the packaging is damaged or appears tampered with.

Why Choose MedicineWalyDost.com?

MedicineWalyDost.com provides product information to help customers explore imported medicines and specialist treatments.

For Ibrutinib 140mg Tablet, customers can contact the website to confirm current availability, price, manufacturer details, pack size, prescription requirements, and delivery options.

Before ordering, verify the product’s exact formulation and packaging. Prescription anticancer medicines should be obtained through an appropriately authorised pharmacy and used under specialist supervision.

Frequently Asked Questions (FAQs)

1. What is Ibrutinib 140mg Tablet used for?

Ibrutinib is a targeted prescription medicine used for certain blood cancers and related conditions, including CLL, SLL, and Waldenström’s macroglobulinaemia, where indicated.

2. How does Ibrutinib work?

It blocks BTK, a protein involved in signalling pathways that help certain abnormal B cells survive and grow.

3. Who is the manufacturer?

The manufacturer specified for this listing is Lucius Pharmaceuticals. Verify the manufacturer’s details on the original packaging.

4. What is the pack size?

The product details provided specify a pack size of 120 tablets. Confirm the actual contents before purchase.

5. Is 140mg the complete daily dose?

Not necessarily. The prescribed dose and schedule depend on the diagnosis, formulation, and individual treatment plan. Follow your specialist’s instructions.

6. What are the common side effects?

Possible side effects include diarrhoea, fatigue, nausea, muscle or joint pain, bruising, rash, and changes in blood cell counts.

7. Does Ibrutinib require medical monitoring?

Yes. Treatment may require regular blood tests and monitoring for bleeding, infections, high blood pressure, heart rhythm problems, and other complications.

8. How can I confirm availability in Pakistan?

Contact MedicineWalyDost.com to confirm current stock, price, prescription requirements, and delivery details.

Contact MedicineWalyDost.com Today

Looking for Ibrutinib 140mg Tablet – Imported? Contact MedicineWalyDost.com to confirm product availability, current price, prescription requirements, and delivery details.

Always use this specialist medicine according to your prescription and under the supervision of a qualified healthcare professional.